Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04732065
Title ONC206 for Treatment of Newly Diagnosed or Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant Brain Tumors (PNOC 023)
Acronym PNOC023
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sabine Mueller, MD, PhD
Indications
Therapies
Age Groups: child | adult
Covered Countries USA


No variant requirements are available.